Here are relevant reports on : risk-assessment-market
-
Enterprise Risk Management (ERM) Market by Solution (Operational Risk Management, Cyber Risk Management, Financial Risk Management, Incident and Crisis Management, Third-party Risk Management) & Service (Professional, Managed) - Global Forecast to 2030
The enterprise risk management (ERM) market is projected to grow from 6.00 billion in 2025 to USD 11.97 billion by 2030, at a CAGR of 14.8% during the forecast period. IBM (US), Microsoft (US), Oracle (US), SAP SE (Germany), SAS Institute (US), ServiceNow (US), FIS (US), Wolters Kluwer (Netherlands), LexisNexis (US), Archer Technologies (US), MetricStream (US), Riskonnect (US), Navex Global (US), OneTrust (US), LogicManager (US), ReadiNow (Australia), Diligent (US), Auditboard (US), SAI360 (US), Protiviti (US), SureCloud (UK), and ProGreC (India) are the key players in the ERM market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Security Assessment Market by Security Type (Endpoint Security, Network Security, Application Security, Cloud Security), Assessment Type, Deployment Mode, Organization Size, Industry Vertical, and Region - Global Forecast to 2022
The security assessment market was valued at USD 1.08 Billion in 2016 and projected to reach USD 4.03 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 26.1% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. Major vendors in the security assessment market include Kaspersky (Russia), IBM (US), FireEye (US), Optiv Security (US), Qualys (US), Trustwave (US), Veracode (US), Check Point (Israel), Absolute Software (Canada), Rapid7 (US), CynergisTek (US), and Positive Technologies (UK).
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
FDI Opportunities in the Indian Defense Sector – Policy Overview, Technological Capability Assessment (Airborne, Naval, and Land), Inventory Gap Assessment (Airborne, Naval, and Land), Key Indian Companies – Capabilities, Tie-ups and Profiles
The Indian Ministry of Defense has been focusing on filling the gaps in the inventory held by Indian armed forces. It has also been focusing on encouraging procurement of defense equipment from indigenous manufacturers. It has initiated the process of signing various contracts with the private sector under the Buy-Make category of the DPP. This is also expected to lead to various partnerships between the Indian companies and global Original Equipment Manufacturers (OEMs) to meet this demand.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021
Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries
Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)
Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024
The clinical risk grouping solutions market is projected to reach USD 829 million by 2024, growing at a CAGR of 14.2% during the forecasting period. The key players in the global clinical risk grouping solutions market are 3M Corporation (US), Optum Inc. (US), Cerner Corporation (US), Conduent Inc. (US), Nuance Communications (US), Health Catalyst (US), HBI Solutions (US), Johns Hopkins University (US), Lightbeam Health Solutions (US), Dynamic Healthcare Systems (US), 4S Information Systems (US), Evolent Health (US) and Pera Health (US).
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Third-Party Risk Management Market by Component (Solution (Financial Control, Contract, Operational Risk, Audit, and Compliance) and Service (Professional & Managed)), Deployment Mode, Organization Size, Vertical, and Region - Global Forecast to 2035
The global third-party risk management (TPRM) market was valued at USD 8.57 billion in 2024 and is projected to reach USD 37.34 billion by 2035, growing at a CAGR of 14.2% between 2025 and 2035. The major vendors covered in the TPRM market include RSA (US), Genpact (US), MetricStream (US), Deloitte (US), KPMG (Netherlands), BitSight Technologies (US), Ernst & Young (UK), PwC (UK), ProcessUnity (US), Venminder (US), Resolver (Canada), NAVEX Global (US), Riskpro (India), SAI Global (US), RapidRatings (US), Optiv (US), Aravo (US), OneTrust (US and UK), Galvanize (Canada), and Prevalent (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
GDPR Services Market by Solution (Data Discovery and Mapping, Data Governance, and API Management), Service (GDPR Readiness Assessment, Risk Assessment and DPIA, and DPO-as-a-Service), Organization Size, and Region - Global Forecast to 2023
The GDPR services market is expected to grow from USD 907.4 million in 2018 to USD 2,659.4 million by 2023, at a Compound Annual Growth Rate (CAGR) of 24.0% during the forecast period. The major drivers of the GDPR services market include the implementation of GDPR by the EU from May 2018, generation of enormous amounts of data, need for data security and privacy, and the demand for data processing transparency leading to improved security service delivery along with the organization’s reputation. Major vendors covered in the GDPR services market include Absolute Software (Canada), Actiance (US), AWS (US), Capgemini (France), Hitachi Systems Security (Canada), IBM (US), Informatica (US), MetricStream (US), Micro Focus (UK), Microsoft (US), Mimecast (UK), Nymity (Canada), OneTrust (US and UK), Oracle (US), Proofpoint (US), Protegrity (US), SAP (Germany), SAS (US), Snow Software (Sweden), Swascan (Italy), Symantec (US), Talend (US), TrustArc (US), Trustwave (US), Varonis (US), and Veritas (US).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Cholesterol Screening/ Cholesterol Testing Services Market by Type of Customer (Physician/Provider, Hospital, Employer, Health Plan, MCO, Government, ACO, IDN, Patient), Geography (North America, Europe) & Qualitative Assessment - - Global Forecast to 2021
The global cholesterol testing services market is expected to reach USD 17.57 Billion by 2021 from an estimated value of USD 11.96 Billion in 2016, growing at a CAGR of 8% during the forecast period. The cholesterol testing market is driven by factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, government initiatives to improve quality of testing, and rapid growth in the geriatric population are propelling the growth of this market. However, rapidly growing home/self-testing and advent of noninvasive cholesterol testing methods are the major factors that may hinder growth of the market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
